Vaccine for Clostridium Botulinum Neurotoxin

Details for Australian Patent Application No. 2002317523 (hide)

Owner Allergan, Inc. Allergan Botox Limited

Inventors Padhye, Nisha V; Thalley, Bruce S; Williams, James A; Firca, Joseph R; Stafford, Douglas C; Kink, John A

Agent Spruson & Ferguson

Pub. Number AU-B-2002317523

Parent 63043

Filing date 9 December 2002

Wipo publication date 10 April 2003

Acceptance publication date 24 June 2004

International Classifications

C07K 016/00 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 015/63 Mutation or genetic engineering - Introduction of foreign genetic material using vectors

G01N 033/569 Investigating or analysing materials by specific methods not covered by groups - for micro-organisms, e.g. protozoa, bacteria, viruses

A61K 039/40 Medicinal preparations containing antigens or antibodies - bacterial

Event Publications

9 January 2003 Complete Application Filed

10 April 2003 Application Open to Public Inspection

  Published as AU-B-2002317523

24 June 2004 Application Accepted

  Published as AU-B-2002317523

21 October 2004 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002317524-Mobile Communication System, Mobile Communication Method, Mobile Terminal and Base Station

2002317522-Braille/tactile embossing